Director Declaration

AstraZeneca PLC

Listing Rule LR 9.6.14 R (2)

On 6 May 2015, Geneviève Berger, Non-Executive Director of AstraZeneca PLC, was appointed as a Director of L'Air Liquide S.A., for a term of four years.

A C N Kemp

Company Secretary

7 May 2015

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit:


Documents & Links